GLP-1 Medication Cost Comparison Tool

Zepbound (semaglutide) is expensive; patients search for cheaper alternatives. A price comparison and eligibility checker for GLP-1 medications across pharmacies, generics, and assistance programs. [Google Search suggestion]

Google TrendsToolMedicine & HealthUSSource
0Sign in to voteCopy link

FL score

72

out of 100

Verdict

VALIDATE

high confidence

Competition

No competitor data yet

Trend

No signal yet

A price aggregator for GLP-1 drugs that shows patients where to buy the same medication cheapest and which assistance programs they qualify for.

The pain

GLP-1 medications cost $900-$1,500/month without insurance. Patients manually call pharmacies, check manufacturer coupons, and dig through eligibility requirements. Many don't know generics exist or that they qualify for patient assistance programs. They either pay full price, skip doses, or abandon treatment.

The gap

No single tool compares GLP-1 prices across pharmacies, generics, biosimilars, and assistance programs in one place. Pharmacy websites don't show prices upfront. Manufacturer programs have separate applications. Patients waste 5-10 hours researching what should take 10 minutes.

Build angle

Start as a simple web tool: user enters zip code and insurance info, tool returns lowest prices at nearby pharmacies plus links to assistance programs they qualify for. Monetize through pharmacy affiliate commissions or B2B licensing to insurance companies and PBMs who want to reduce member costs.

Strengths

  • Clear, measurable pain: patients actively searching for lower prices (Google Trends signal is real)
  • High-value outcome: saving $200-500/month per patient is meaningful enough to drive adoption
  • Recurring revenue potential: patients refill monthly, creating predictable affiliate or licensing revenue
  • Regulatory tailwind: insurers and PBMs actively want tools that reduce GLP-1 spend
  • Data advantage: pharmacy price data and assistance program eligibility rules are obtainable but require work to aggregate

Risks

  • Pharmacy data is fragmented and changes weekly; maintaining accuracy requires constant updates or API partnerships that may not exist
  • Pharmacies actively hide prices to prevent comparison shopping; you may hit legal or technical walls accessing real-time pricing
  • Assistance programs have complex, changing eligibility rules; incorrect guidance creates liability and user distrust
  • Market consolidation: major PBMs (CVS Caremark, Express Scripts) may build this themselves or block third-party access to their data
  • Monetization friction: pharmacies may not pay affiliate commissions on price-sensitive customers; PBMs may demand exclusivity or data ownership
  • User acquisition cost may be high if patients don't actively search for this tool; SEO and paid search are competitive

Questions about this idea?

FlyBot reads the scoring and gives you a second opinion on “GLP-1 Medication Cost Comparison Tool”.

Open FlyBot